Works matching IS 09441174 AND DT 2024 AND VI 59 AND IP 11
Results: 7
Advances in omics data for eosinophilic esophagitis: moving towards multi-omics analyses.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 11, p. 963, doi. 10.1007/s00535-024-02151-6
- By:
- Publication type:
- Article
Multisample lipidomic profiles of irritable bowel syndrome and irritable bowel syndrome-like symptoms in patients with inflammatory bowel disease: new insight into the recognition of the same symptoms in different diseases.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 11, p. 1000, doi. 10.1007/s00535-024-02148-1
- By:
- Publication type:
- Article
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 11, p. 986, doi. 10.1007/s00535-024-02147-2
- By:
- Publication type:
- Article
Single-molecule sequencing of the whole HCV genome revealed envelope deletions in decompensated cirrhosis associated with NS2 and NS5A mutations.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 11, p. 1021, doi. 10.1007/s00535-024-02146-3
- By:
- Publication type:
- Article
The risk stratification and predictive performance of a new combined polygenic risk score for hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 11, p. 1011, doi. 10.1007/s00535-024-02144-5
- By:
- Publication type:
- Article
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 11, p. 1037, doi. 10.1007/s00535-024-02145-4
- By:
- Publication type:
- Article
Prognostic factors of second-line nivolumab monotherapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study for 184 cases.
- Published in:
- Journal of Gastroenterology, 2024, v. 59, n. 11, p. 979, doi. 10.1007/s00535-024-02141-8
- By:
- Publication type:
- Article